{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:26:25Z","timestamp":1774538785105,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:00:00Z","timestamp":1482969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00406-016-0757-7","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:24:11Z","timestamp":1482971051000},"page":"427-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia"],"prefix":"10.1007","volume":"267","author":[{"given":"Hans-Gert","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Dobrowolny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Wolke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Lendeckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Bukowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerburg","family":"Keilhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Tr\u00fcbner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Bogerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,29]]},"reference":[{"key":"757_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1017\/S1092852914000601","volume":"1","author":"M Carbon","year":"2014","unstructured":"Carbon M, Correll CU (2014) Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia. CNS Spectr Suppl 1:38\u201352. doi:\n                        10.1017\/S1092852914000601","journal-title":"CNS Spectr Suppl"},{"key":"757_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40263-016-0315-x","volume":"30","author":"PD Shilling","year":"2016","unstructured":"Shilling PD, Feifel D (2016) Potential of oxytocin in the treatment of schizophrenia. CNS Drugs 30:193\u2013208. doi:\n                        10.1007\/s40263-016-0315-x","journal-title":"CNS Drugs"},{"key":"757_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejphar.2007.11.063","volume":"583","author":"E Frank","year":"2008","unstructured":"Frank E, Landgraf R (2008) The vasopressin system\u2013from antidiuresis to psychopathology. Eur Pharmacol 583:226\u2013242. doi:\n                        10.1016\/j.ejphar.2007.11.063","journal-title":"Eur Pharmacol"},{"key":"757_CR4","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/schbul\/sbu","volume":"40","author":"LH Rubin","year":"2014","unstructured":"Rubin LH, Carter CS, Bishop JR, Pournajafi-Nazarloo H, Drogos LL, Hill SK, Ruocco AC, Keedy SK, Reilly JL, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Sweeney JA (2014) Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull 40:1374\u20131384. doi:\n                        10.1093\/schbul\/sbu","journal-title":"Schizophr Bull"},{"issue":"90","key":"757_CR5","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3389\/fendo.2015.00090","volume":"6","author":"ME Rich","year":"2015","unstructured":"Rich ME, Caldwell HK (2015) A role for oxytocin in the etiology and treatment of schizophrenia. Front Endocrinol 6(90):2015. doi:\n                        10.3389\/fendo.2015.00090\n                        \n                     (eCollection 2015)","journal-title":"Front Endocrinol"},{"key":"757_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.biopsych.2015.07.025","volume":"79","author":"D Feifel","year":"2016","unstructured":"Feifel D, Shilling PD, MacDonald K (2016) A review of oxytocin\u2019s effects on the positive, negative, and cognitive domains of schizophrenia. Biol Psychiatry 79:222\u2013233. doi:\n                        10.1016\/j.biopsych.2015.07.025","journal-title":"Biol Psychiatry"},{"key":"757_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.04.019","author":"S Uhrig","year":"2016","unstructured":"Uhrig S, Hirth N, Broccoli L, von Wilmsdorff M, Bauer M, Sommer C, Zink M, Steiner J, Frodl T, Malchow B, Falkai P, Spanagel R, Hansson AC, Schmitt A (2016) Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: a post-mortem study. Schizophr Res. doi:\n                        10.1016\/j.schres.2016.04.019","journal-title":"Schizophr Res"},{"key":"757_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00406-015-0634-9","volume":"26","author":"K Oya","year":"2016","unstructured":"Oya K, Matsuda Y, Matsunaga S, Kishi T, Iwata N (2016) Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials. Eur Arch Psychiatry Clin Neurosci 26:439\u2013450. doi:\n                        10.1007\/s00406-015-0634-9","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"757_CR9","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/npp.2014.68","volume":"39","author":"MC Davis","year":"2014","unstructured":"Davis MC, Green MF, Lee J, Horan WP, Senturk D, Clarke AD, Marder SR (2014) Oxytocin-augmented social cognitive skills training in schizophrenia. Neuropsychopharmacology 39:2070\u20132077. doi:\n                        10.1038\/npp.2014.68","journal-title":"Neuropsychopharmacology"},{"key":"757_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/schbul\/sbu094","volume":"4","author":"C Cacciotti-Saija","year":"2015","unstructured":"Cacciotti-Saija C, Langdon R, Ward PB, Hickie IB, Scott EM, Naismith SL, Moore L, Alvares GA, Redoblado Hodge MA, Guastella AJ (2015) A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis. Schizophr Bull 4:483\u2013493. doi:\n                        10.1093\/schbul\/sbu094","journal-title":"Schizophr Bull"},{"key":"757_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.schres.2014.12.029","volume":"162","author":"PG Michalopoulou","year":"2015","unstructured":"Michalopoulou PG, Averbeck BB, Kalpakidou AK, Evans S, Bobin T, Kapur S, Shergill SS (2015) The effects of a single dose of oxytocin on working memory in schizophrenia. Schizophr Res 162:62\u201363. doi:\n                        10.1016\/j.schres.2014.12.029","journal-title":"Schizophr Res"},{"key":"757_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1124\/mol.115.102533","volume":"89","author":"S Diwakarla","year":"2016","unstructured":"Diwakarla S, Nylander E, Gr\u00f6nbladh A, Vanga SR, Khan YS, Guti\u00e9rrez-de-Ter\u00e1n H, Ng L, Pham V, S\u00e4vmarker J, Lundb\u00e4ck T, Jenmalm-Jensen A, Andersson H, Engen K, Rosenstr\u00f6m U, Larhed M, \u00c5qvist J, Chai SY, Hallberg M (2016) Binding to and inhibition of insulin-regulated aminopeptidase by macrocyclic disulfides enhances spine density. Mol Pharmacol 89:413\u2013424. doi:\n                        10.1124\/mol.115.102533","journal-title":"Mol Pharmacol"},{"issue":"1\u20133","key":"757_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.schres.2010.04.019","volume":"121","author":"RP Souza","year":"2010","unstructured":"Souza RP, Ismail P, Meltzer HY, Kennedy JL (2010) Variants in the oxytocin gene and risk for schizophrenia. Schizophr Res 121(1\u20133):279\u2013280. doi:\n                        10.1016\/j.schres.2010.04.019","journal-title":"Schizophr Res"},{"key":"757_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.yhbeh.2011.12.014","volume":"61","author":"RP Ebstein","year":"2012","unstructured":"Ebstein RP, Knafo AP, Mankuta D, Chew SH, Lai PS (2012) The contributions of oxytocin and vasopressin pathway genes to human behavior. Horm Behav 61:359\u2013379. doi:\n                        10.1016\/j.yhbeh.2011.12.014","journal-title":"Horm Behav"},{"key":"757_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1017\/S1461145711001374","volume":"15","author":"O Teltsh","year":"2012","unstructured":"Teltsh O, Kanyas-Sarner K, Rigbi A, Greenbaum L, Lerer B, Kohn Y (2012) Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree. Int J Neuropsychopharmacol 15:309\u2013319. doi:\n                        10.1017\/S1461145711001374","journal-title":"Int J Neuropsychopharmacol"},{"key":"757_CR16","doi-asserted-by":"publisher","first-page":"e664","DOI":"10.1038\/tp.2015.163","volume":"5","author":"FS Chen","year":"2015","unstructured":"Chen FS, Kumsta R, Dvorak F, Domes G, Yim OS, Ebstein RP, Heinrichs M (2015) Genetic modulation of oxytocin sensitivity: a pharmacogenetic approach. Transl Psychiatry 5:e664. doi:\n                        10.1038\/tp.2015.163","journal-title":"Transl Psychiatry"},{"key":"757_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2007.09.019","volume":"98","author":"M Goldman","year":"2008","unstructured":"Goldman M, Marlow-O\u2019Connor M, Torres I, Carter CS (2008) Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophr Res 98:247\u2013255","journal-title":"Schizophr Res"},{"key":"757_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/neu.2014.20","volume":"26","author":"A Jobst","year":"2014","unstructured":"Jobst A, Dehning S, Ruf S, Notz T, Buchheim A, Henning-Fast K, Mei\u00dfner D, Meyer S, Bondy B, M\u00fcller N, Zill P (2014) Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients. Acta Neuropsychiatr 26:347\u2013355. doi:\n                        10.1017\/neu.2014.20","journal-title":"Acta Neuropsychiatr"},{"key":"757_CR19","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.psyneuen.2003.08.011","volume":"29","author":"MC Ryan","year":"2004","unstructured":"Ryan MC, Sharifi N, Condren R, Thakore JH (2004) Evidence of basal pituitary\u2013adrenal overactivity in first episode, drug na\u00efve patients with schizophrenia. Psychoneuroendocrinology 29:1065\u20131070","journal-title":"Psychoneuroendocrinology"},{"key":"757_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/10298420290031432","volume":"4","author":"De Wied","year":"2002","unstructured":"Wied De, Sigling HO (2002) Neuropeptides involved in the pathophysiology of schizophrenia and major depression. Neurotox Res 4:453\u2013468","journal-title":"Neurotox Res"},{"key":"757_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3109\/15622975.2011.601759","volume":"14","author":"D Krishnamurthy","year":"2013","unstructured":"Krishnamurthy D, Harris LW, Levin Y, Koutroukides TA, Rahmoune H, Pietsch S, Vanattou-Saifoudine N, Leweke FM, Guest PC, Bahn S (2013) Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects. World J Biol Psychiatry 14:478\u2013489. doi:\n                        10.3109\/15622975.2011.601759","journal-title":"World J Biol Psychiatry"},{"key":"757_CR22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0447.1991.tb05539.x","volume":"83","author":"SO Frederiksen","year":"1991","unstructured":"Frederiksen SO, Ekman R, Gottfries CG, Widerlov E, Jonsson S (1991) Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics. Acta Psychiatr Scand 83:273\u2013277","journal-title":"Acta Psychiatr Scand"},{"key":"757_CR23","first-page":"133","volume":"34","author":"JK Mai","year":"1993","unstructured":"Mai JK, Berger K, Sofroniew MV (1993) Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. J Hirnforsch 34:133\u2013154","journal-title":"J Hirnforsch"},{"key":"757_CR24","doi-asserted-by":"crossref","first-page":"E1092","DOI":"10.1152\/ajpendo.00440.2007","volume":"293","author":"MG Wallis","year":"2007","unstructured":"Wallis MG, Lankford MF, Keller SR (2007) Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. Am J Physiol Endocrinol Metab 293:E1092\u2013E1102","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"757_CR25","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.10-2517","volume":"139","author":"TA Nakada","year":"2011","unstructured":"Nakada TA, Russell JA, Wellman H, Boyd JH, Nakada E, Thain KR, Thair SA, Hirasawa H, Oda S, Walley KR (2011) Leucyl\/cystinyl aminopeptidase gene variants in septic shock. Chest 139:1042\u20131049","journal-title":"Chest"},{"key":"757_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s13277-010-0149-y","volume":"32","author":"MP Carrera-Gonz\u00e1lez","year":"2011","unstructured":"Carrera-Gonz\u00e1lez MP, Ram\u00edrez-Exp\u00f3sito MJ, de Saavedra JM, S\u00e1nchez-Agesta R, Mayas MD, Mart\u00ednez-Martos JM (2011) Hypothalamus\u2013pituitary\u2013thyroid axis disruption in rats with breast cancer is related to an altered endogenous oxytocin\/insulin-regulated aminopeptidase (IRAP) system. Tumour Biol 32:543\u2013549. doi:\n                        10.1007\/s13277-010-0149-y","journal-title":"Tumour Biol"},{"key":"757_CR27","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1017\/S1461145712001149","volume":"16","author":"E Loyens","year":"2013","unstructured":"Loyens E, De Bundel D, Demaegdt H, Chai SY, Vanderheyden P, Michotte Y, Gard P, Smolders I (2013) Antidepressant-like effects of oxytocin in mice are dependent on the presence of insulin-regulated aminopeptidase. Int J Neuropsychopharmacol 16:1153\u20131163. doi:\n                        10.1017\/S1461145712001149","journal-title":"Int J Neuropsychopharmacol"},{"key":"757_CR28","first-page":"307","volume-title":"Handbook of proteolytic enzymes","author":"K Bauer","year":"2004","unstructured":"Bauer K (2004) Cystinyl aminopeptidase, oxytocinase and insulin-regulated aminopeptidase. In: Barret AJ, Rawlings ND, Woessner JF (eds) Handbook of proteolytic enzymes, 2nd edn. Elsevier Academic Press, London, pp 307\u2013313","edition":"2"},{"issue":"2","key":"757_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.psychres.2015.04.027","volume":"228","author":"A Fern\u00e1ndez-Atucha","year":"2015","unstructured":"Fern\u00e1ndez-Atucha A, Echevarr\u00eda E, Larrinaga G, Gil J, Mart\u00ednez-Cengotitabengoa M, Gonz\u00e1lez-Pinto AM, Irazusta J, Seco J (2015) Plasma peptidases as prognostic biomarkers in patients with first-episode psychosis. Psychiatry Res 228(2):197\u2013202. doi:\n                        10.1016\/j.psychres.2015.04.027","journal-title":"Psychiatry Res"},{"key":"757_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lfs.2015.04.023","volume":"134","author":"I Prieto","year":"2015","unstructured":"Prieto I, Villarejo AB, Segarra AB, Wangensteen R, Banegas I, de Gasparo M, Vanderheyden P, Zorad S, Vives F, Ram\u00edrez-S\u00e1nchez M (2015) Tissue distribution of CysAP activity and its relationship to blood pressure and water balance. Life Sci 134:73\u201378. doi:\n                        10.1016\/j.lfs.2015.04.023","journal-title":"Life Sci"},{"key":"757_CR31","unstructured":"Chissoe S, Ehm MG, Jean St. P (2008) Genes associated with schizophrenia. US Patent Appl 20080176239; p 80"},{"key":"757_CR32","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1093\/hmg\/ddt350","volume":"22","author":"AR Sanders","year":"2013","unstructured":"Sanders AR, G\u00f6ring HH, Duan J, Drigalenko EI, Moy W, Freda J, He D, Shi JMGS, Gejman PV (2013) Transcriptome study of differential expression in schizophrenia. Hum Mol Genet 22:5001\u201350014. doi:\n                        10.1093\/hmg\/ddt350","journal-title":"Hum Mol Genet"},{"key":"757_CR33","first-page":"61","volume-title":"Aminopeptidases in biology and disease","author":"SY Chai","year":"2012","unstructured":"Chai SY, Fernando R, Ye S, Peck GR, Albiston AL (2012) Insulin-regulated aminopeptidase. In: Hopper N, Lendeckel U (eds) Aminopeptidases in biology and disease. Springer, New York, pp 61\u201382"},{"issue":"5","key":"757_CR34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2174\/1871527311312050010","volume":"12","author":"AL LaCrosse","year":"2013","unstructured":"LaCrosse AL, Olive MF (2013) Neuropeptide systems and schizophrenia. CNS Neurol Disord Drug Targets 12(5):619\u2013632","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"757_CR35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2006.11.010","volume":"1131","author":"B Stragier","year":"2007","unstructured":"Stragier B, Demaegdt H, De Bundel D, Smolders I, Sarre S, Vauquelin G, Ebinger G, Michotte Y, Vanderheyden P (2007) Involvement of insulin-regulated aminopeptidase and\/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat. Brain Res 1131:97\u2013105","journal-title":"Brain Res"},{"key":"757_CR36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fnbeh.2014.00188","volume":"8","author":"R Cachope","year":"2014","unstructured":"Cachope R, Cheer JF (2014) Local control of striatal dopamine release. Front Behav Neurosci 8:188. doi:\n                        10.3389\/fnbeh.2014.00188\n                        \n                     (eCollection 2014)","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"757_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fimmu.2012.00057","volume":"21","author":"L Saveanu","year":"2012","unstructured":"Saveanu L, van Endert P (2012) The role of insulin-regulated aminopeptidase in MHC class I antigen presentation. Front Immunol 21(3):57. doi:\n                        10.3389\/fimmu.2012.00057\n                        \n                     (eCollection 2012)","journal-title":"Front Immunol"},{"key":"757_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.biopsych.2013.10.003","volume":"75","author":"AK McAllister","year":"2014","unstructured":"McAllister AK (2014) Major histocompatibility complex I in brain development and schizophrenia. Biol Psychiatry 75:262\u2013268. doi:\n                        10.1016\/j.biopsych.2013.10.003","journal-title":"Biol Psychiatry"},{"key":"757_CR39","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1460-9568.2008.06347.x","volume":"28","author":"RN Fernando","year":"2008","unstructured":"Fernando RN, Albiston AL, Chai SY (2008) The insulin-regulated aminopeptidase IRAP is colocalised with GLUT4 in the mouse hippocampus\u2013potential role in modulation of glucose uptake in neurones? Eur J Neurosci 28:588\u2013598. doi:\n                        10.1111\/j.1460-9568.2008.06347.x","journal-title":"Eur J Neurosci"},{"key":"757_CR40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/1469-8986.3520186","volume":"35","author":"EA Hazlett","year":"1998","unstructured":"Hazlett EA, Buchsbaum MS, Haznedar MM, Singer MB, Germans MK, Schnur DB, Jimenez EA, Buchsbaum BR, Troyer BT (1998) Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology 35:186\u2013198","journal-title":"Psychophysiology"},{"key":"757_CR41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0891-0618(00)00112-5","volume":"20","author":"SY Chai","year":"2000","unstructured":"Chai SY, Bastias MA, Clune EF, Matsacos DJ, Mustafa T, Lee JH, McDowall SG, Paxinos G, Mendelsohn FA, Albiston AL (2000) Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography. J Chem Neuroanat 20:339\u2013348","journal-title":"J Chem Neuroanat"},{"key":"757_CR42","doi-asserted-by":"crossref","first-page":"48623","DOI":"10.1074\/jbc.C100512200","volume":"276","author":"AL Albiston","year":"2001","unstructured":"Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, Connolly LM, Chai SY (2001) Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276:48623\u201348626","journal-title":"J Biol Chem"},{"key":"757_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nlm.2009.07.011","volume":"93","author":"AL Albiston","year":"2010","unstructured":"Albiston AL, Fernando RN, Yeatman HR, Burns P, Ng L, Daswani D, Diwakarla S, Pham V, Chai SY (2010) Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory. Neurobiol Learn Mem 93:19\u201330. doi:\n                        10.1016\/j.nlm.2009.07.011","journal-title":"Neurobiol Learn Mem"},{"key":"757_CR44","doi-asserted-by":"publisher","first-page":"789671","DOI":"10.1155\/2012\/789671","volume":"2012","author":"H Andersson","year":"2012","unstructured":"Andersson H, Hallberg M (2012) Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers. Int J Hypertens 2012:789671. doi:\n                        10.1155\/2012\/789671","journal-title":"Int J Hypertens"},{"key":"757_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-002-0655-3","volume":"311","author":"Von Bohlen","year":"2003","unstructured":"Bohlen Von, Halbach O (2003) Angiotensin IV in the central nervous system. Cell Tissue Res 311:1\u20139","journal-title":"Cell Tissue Res"},{"key":"757_CR46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cne.20585","volume":"487","author":"RN Fernando","year":"2005","unstructured":"Fernando RN, Larm J, Albiston AL, Chai SY (2005) Distribution and cellular localization of insulin-regulated aminopeptidase in the rat central nervous system. J Comp Neurol 487:372\u2013390","journal-title":"J Comp Neurol"},{"key":"757_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jne.12141","volume":"26","author":"VA Tobin","year":"2014","unstructured":"Tobin VA, Arechaga G, Brunton PJ, Russell JA, Leng G, Ludwig M, Douglas AJ (2014) Oxytocinase in the female rat hypothalamus: a novel mechanism controlling oxytocin neurones during lactation. J Neuroendocrinol 26:205\u2013216. doi:\n                        10.1111\/jne.12141","journal-title":"J Neuroendocrinol"},{"key":"757_CR48","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1017\/S1461145713000199","volume":"16","author":"S M\u00fcller","year":"2013","unstructured":"M\u00fcller S, Lendeckel U, Dobrowolny H, Steiner J, Bogerts B, Bernstein HG (2013) Some notes on insulin-regulated aminopeptidase in depression. Int J Neuropsychopharmacol 16:1877\u20131878. doi:\n                        10.1017\/S1461145713000199","journal-title":"Int J Neuropsychopharmacol"},{"key":"757_CR49","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.psyneuen.2007.12.002","volume":"33","author":"HG Bernstein","year":"2008","unstructured":"Bernstein HG, Lendeckel U, Dobrowolny H, Stauch R, Steiner J, Grecksch G, Becker A, Jirikowski GF, Bogerts B (2008) Beacon-like\/ubiquitin-5-like immunoreactivity is highly expressed in human hypothalamus and increased in haloperidol-treated schizophrenics and a rat model of schizophrenia. Psychoneuroendocrinology. 33:340\u2013351. doi:\n                        10.1016\/j.psyneuen.2007.12.002","journal-title":"Psychoneuroendocrinology."},{"key":"757_CR50","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0306-4522(97)00461-2","volume":"83","author":"HG Bernstein","year":"1998","unstructured":"Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, Falkai P, Bogerts B (1998) Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83:867\u2013875","journal-title":"Neuroscience"},{"key":"757_CR51","volume-title":"Atlas of the human brain","author":"JK Mai","year":"2003","unstructured":"Mai JK, Paxinos G, Assheuer JK (2003) Atlas of the human brain. Elsevier Academic Press, Amsterdam"},{"key":"757_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fncel.2015.00273","volume":"9","author":"HG Bernstein","year":"2015","unstructured":"Bernstein HG, Meyer-Lotz G, Dobrowolny H, Bannier J, Steiner J, Walter M, Bogerts B (2015) Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder. Front Cell Neurosci 9:273. doi:\n                        10.3389\/fncel.2015.00273\n                        \n                     (eCollection 2015)","journal-title":"Front Cell Neurosci"},{"key":"757_CR53","first-page":"279","volume":"51","author":"HG Bernstein","year":"2005","unstructured":"Bernstein HG, Heinemann A, Krell D, Dobrowolny H, Bielau H, Keilhoff G, Bogerts B (2005) Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. Cell Mol Biol 51:279\u2013284","journal-title":"Cell Mol Biol"},{"key":"757_CR54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/frne.1997.0154","volume":"18","author":"I Gerendai","year":"1997","unstructured":"Gerendai I, Hal\u00e1sz B (1997) Neuroendocrine asymmetry. Front Neuroendocrinol 18:354\u2013381","journal-title":"Front Neuroendocrinol"},{"key":"757_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jchemneu.2014.07.003","volume":"61\u201362","author":"HG Bernstein","year":"2014","unstructured":"Bernstein HG, Bannier J, Meyer-Lotz G, Steiner J, Keilhoff G, Dobrowolny H, Walter M, Bogerts B (2014) Distribution of immunoreactive glutamine synthetase in the adult human and mouse brain. Qualitative and quantitative observations with special emphasis on extra-astroglial protein localization. J Chem Neuroanat 61\u201362:33\u201350. doi:\n                        10.1016\/j.jchemneu.2014.07.003","journal-title":"J Chem Neuroanat"},{"key":"757_CR56","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1210\/jcem.87.3.8306","volume":"87","author":"S Toda","year":"2002","unstructured":"Toda S, Ando H, Nagasaka T, Tsukahara S, Nomura M, Kotani Y, Nomura S, Kikkawa F, Tsujimoto M, Mizutani S (2002) Existence of placental leucine aminopeptidase\/oxytocinase\/insulin-regulated membrane aminopeptidase in human endometrial epithelial cells. J Clin Endocrinol Metab 87:1384\u20131389","journal-title":"J Clin Endocrinol Metab"},{"key":"757_CR57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1876528901003010059","volume":"3","author":"HG Bernstein","year":"2010","unstructured":"Bernstein HG, Keilhoff G, Steiner J, Dobrowolny H, Bogerts B (2010) The hypothalamus in schizophrenia research: no longer a wallflower existence. Open Neuroendocrinol J 3:59\u201367","journal-title":"Open Neuroendocrinol J"},{"key":"757_CR58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000090981","volume":"82","author":"YI Malidelis","year":"2005","unstructured":"Malidelis YI, Panayotacopoulou MT, van Heerikhuize JJ, Unme-Hopa U, Kontostavlaki DP, Swaab DF (2005) Absence of a difference in the neurosecretory activity of supraoptic nucleus of vasopressin neurons of neuroleptic-treated schizophrenic patients. Neuroendocrinology 82:63\u201369","journal-title":"Neuroendocrinology"},{"key":"757_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/archpsyc.1996.01830020055007","volume":"53","author":"JS Purba","year":"1996","unstructured":"Purba JS, Hoogendijk WJ, Hofman MA, Swaab D (1996) Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 53:137\u2013143. doi:\n                        10.1001\/archpsyc.1996.01830020055007","journal-title":"Arch Gen Psychiatry"},{"key":"757_CR60","doi-asserted-by":"crossref","first-page":"533","DOI":"10.12740\/PP\/OnlineFirst\/33485","volume":"50","author":"B Kasparek-Zymowska","year":"2016","unstructured":"Kasparek-Zymowska B, Zymowski Z, Biernacka K, Kucharska K, Rybakowski F (2016) Impaired social recognition in Asperger syndrome and anorexia nervosa. In search for endophenotypes of social cognition. Psychiatr Pol 50:533\u2013542","journal-title":"Psychiatr Pol"},{"key":"757_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00271","author":"C Theofanopoulou","year":"2016","unstructured":"Theofanopoulou C (2016) Implications of oxytocin in human linguistic cognition: from genome to phenome. Front Neurosci. doi:\n                        10.3389\/fnins.2016.00271","journal-title":"Front Neurosci"},{"key":"757_CR62","unstructured":"Almeida D (2015) Oxytocin: a neurohormone link to the epigenetics of early life adversity and suicide. Poster, RQSHA research day 2015, Quebec, Canada"},{"key":"757_CR63","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/1570159X11311020008","volume":"11","author":"N Japund\u017ei\u0107-\u017digon","year":"2013","unstructured":"Japund\u017ei\u0107-\u017digon N (2013) Vasopressin and oxytocin in control of the cardiovascular system. Curr Neuropharmacol 11:218\u2013230. doi:\n                        10.2174\/1570159X11311020008","journal-title":"Curr Neuropharmacol"},{"key":"757_CR64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11126-011-9189-8","volume":"83","author":"JN Shah","year":"2012","unstructured":"Shah JN, Qureshi SU, Jawaid A, Schulz PE (2012) Is there evidence for late cognitive decline in chronic schizophrenia? Psychiatr Q 83:127\u2013144. doi:\n                        10.1007\/s11126-011-9189-8","journal-title":"Psychiatr Q"},{"key":"757_CR65","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.yhbeh.2006.04.009","volume":"50","author":"M Engelmann","year":"2006","unstructured":"Engelmann M, Ebner K, Landgraf R, Wotjak CT (2006) Effects of Morris water maze testing on the neuroendocrine stress response and intrahypothalamic release of vasopressin and oxytocin in the rat. Horm Behav 50:496\u2013501","journal-title":"Horm Behav"},{"key":"757_CR66","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.neuropsychologia.2005.10.005","volume":"44","author":"M Asselen Van","year":"2006","unstructured":"Van Asselen M, Kessels RP, Neggers SF, Kappelle LJ, Frijns CJ, Postma A (2006) Brain areas involved in spatial working memory. Neuropsychologia 44:1185\u20131194","journal-title":"Neuropsychologia"},{"key":"757_CR67","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/(SICI)1096-9861(19970714)383:4<397::AID-CNE1>3.0.CO;2-Y","volume":"383","author":"J Dai","year":"1997","unstructured":"Dai J, Swaab DF, Buijs JM (1997) Distribution of vasopressin and vasoactive intestinal polypeptide (VIP) fibers in the human hypothalamus with special emphasis on suprachiasmatic nucleus efferent projections. J Comp Neurol 383:397\u2013414","journal-title":"J Comp Neurol"},{"key":"757_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0029-1234081","volume":"42","author":"EV Sivukhina","year":"2010","unstructured":"Sivukhina EV, Morozov IuE, Dolzhikov AA, Jirikowski GF, Grinevich V (2010) Comparison of vasopressin and oxytocin expressions in the hypothalamo-neurohypophysial system of patients with chronic heart failure. Horm Metab Res 42:56\u201360. doi:\n                        10.1055\/s-0029-1234081","journal-title":"Horm Metab Res"},{"key":"757_CR69","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nn.2503","volume":"13","author":"E Trudel","year":"2010","unstructured":"Trudel E, Bourque CW (2010) Central clock excites vasopressin neurons by waking osmosensory afferents during late sleep. Nat Neurosci 13:467\u2013474. doi:\n                        10.1038\/nn.2503","journal-title":"Nat Neurosci"},{"key":"757_CR70","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.mehy.2009.07.019","volume":"74","author":"SN Trbovic","year":"2010","unstructured":"Trbovic SN (2010) Schizophrenia as a possible dysfunction of the suprachiasmatic nucleus. Med Hypotheses 74:127\u2013131. doi:\n                        10.1016\/j.mehy.2009.07.019","journal-title":"Med Hypotheses"},{"key":"757_CR71","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1248\/bpb.27.761","volume":"27","author":"SR Keller","year":"2004","unstructured":"Keller SR (2004) Role of the insulin-regulated aminopeptidase IRAP in insulin action and diabetes. Biol Pharm Bull 27:761\u2013764","journal-title":"Biol Pharm Bull"},{"key":"757_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbrc.2014.12.071","volume":"457","author":"M Niwa","year":"2015","unstructured":"Niwa M, Numaguchi Y, Ishii M, Kuwahata T, Kondo M, Shibata R, Miyata K, Oike Y, Murohara T (2015) IRAP deficiency attenuates diet-induced obesity in mice through increased energy expenditure. Biochem Biophys Res Commun 457:12\u201318. doi:\n                        10.1016\/j.bbrc.2014.12.071","journal-title":"Biochem Biophys Res Commun"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-016-0757-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-016-0757-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-016-0757-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T08:03:24Z","timestamp":1499933004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-016-0757-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,29]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1007\/s00406-016-0757-7","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,29]]}}}